DMD #16725 EFFECT OF RESVERATROL ON 17ß-ESTRADIOL SULFATION BY HUMAN HEPATIC AND JEJUNAL S9 AND RECOMBINANT SULT1E1 Anna M. Furimsky, Carol E. Green, Lewanne E. Hunt Sharp, Paul Catz, Araba A. Adjei, Toufan Parman, Izet M. Kapetanovic, Richard M. Weinshilboum, Lalitha V. Iyer. Toxicology and Metabolism (A.M.F., C.E.G., L.E.H.S., P.C., T.P., L.V.I.), Biosciences Division, SRI International, Menlo Park, CA 94025, Department of Pharmacology and Therapeutics (A.A.A), Roswell Park Cancer Institute, Buffalo, NY 14263, Division of Clinical Pharmacology (R.M.W.), Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN 55905, and Chemopreventive Agent Development Research Group (I.M.K.), Division of Cancer Prevention, National Cancer Institute, Bethesda, MD 20892. DMD Fast Forward. Published on October 22, 2007 as doi:10.1124/dmd.107.016725 Copyright 2007 by the American Society for Pharmacology and Experimental Therapeutics. This article has not been copyedited and formatted. The final version may differ from this version. DMD Fast Forward. Published on October 22, 2007 as DOI: 10.1124/dmd.107.016725 at ASPET Journals on August 15, 2017 dmd.aspetjournals.org Downloaded from